Ted did his undergraduate degree at the University of British Columbia where he became fascinated with the diverse optical designs of eyes. In 1981 he came to the then Research School of Biological Sciences (now part of RSB) at the ANU to do a PhD on insect vision but finished up working on nonlinear adaptive mechanisms in mammalian visual cortex. Ted then briefly moved to the John Curtin School of Medical Research to carry on with the cortical work but instead exploited a retinal adaptation mechanism to invent a new stimulus for mapping the visual fields (perimetry) for diseases like glaucoma. The resulting patents are used in the FDT and Matrix perimeters sold by Carle Zeiss Meditech. That work caused Ted to work more on human vision in health and disease. In late 2012 his group moved to the new Clinical Suite of the ANU Eccles Institute for Neuroscience (EIN) at the John Curtin School of Medical Research. Ted is the recent past Director of a national research body: the ARC Vision Centre. He is currently part of the Canberra area clincial research consortium, Vision ACTion. His group is working with Konan Medical to deliver the world's first objective visual field test, the objectiveFIELD.

.

PhD

Visual field testing for eye diseases and development of such technologies

Commercialisation

Texture vision